Generic Drugs Market Size, Share, Trends, and Forecast 2032

Generic Drugs Market

Generic Drugs Market By Brand (Pure generic drugs, Branded generic drugs) By Application (Central nervous system (CNS), Cardiovascular, Dermatology, Oncology, Respiratory, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032

Category: Pharmaceutical Report Format : PDF Pages: 160 Report Code: ZMR-212 Published Date: Dec-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 359.27 Billion USD 593.71 Billion 5.74% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Brand
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Generic Drugs Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Generic Drugs Market – Brand Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Brand, 2020 & 2028
    • 4.2. Pure generic drugs
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Branded generic drugs
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Generic Drugs Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Central nervous system (CNS)
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Cardiovascular
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Dermatulogy
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Onculogy
      • 5.5.1. Market Size and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Respiratory
      • 5.6.1. Market Size and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Others
      • 5.7.1. Market Size and Forecast, By Region (USD Billion)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Brand, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Brand, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Brand, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Brand, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Brand, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Brand, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Brand, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Brand, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Brand, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Brand, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Brand, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Brand, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Brand, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Brand, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Brand, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Brand, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Brand, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Brand, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Brand, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Brand, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Brand, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Brand, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Brand, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Brand, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Brand, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Brand, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7: Generic Drugs Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Brand Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Generic Drugs Market: Company Market Share, 2019
      • 8.1.2. Global Generic Drugs Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Generic Drugs Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Generic Drugs Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. TEVA PHARMACEUTICAL INDUSTRIES LTD
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Novartis International AG
    • 9.3. Mylan N.V
    • 9.4. Abbott Healthcare Pvt Ltd
    • 9.5. Actavis Pharmaceuticals
    • 9.6. Sun Pharmaceuticals
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Brand
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Generic Drugs Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Brand, 2020 & 2028 
FIG NO. 7. Global Generic Drugs Market for Pure generic drugs, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Generic Drugs Market for Pure generic drugs, By Country, 2020 & 2028
FIG NO. 9. Global Generic Drugs Market for Branded generic drugs, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Generic Drugs Market for Branded generic drugs, By Country, 2020 & 2028
FIG NO. 11. Global Generic Drugs Market for Oncology, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Generic Drugs Market for Oncology, By Country, 2020 & 2028
FIG NO. 13. Global Generic Drugs Market for Respiratory, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Generic Drugs Market for Respiratory, By Country, 2020 & 2028
FIG NO. 15. Global Generic Drugs Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Generic Drugs Market for Others, By Country, 2020 & 2028
FIG NO. 17. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 18. Global Generic Drugs Market for Central nervous system (CNS), Revenue (USD Billion) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Generic Drugs Market for Central nervous system (CNS), By Country, 2020 & 2028 
FIG NO. 20. Global Generic Drugs Market for Cardiovascular, Revenue (USD Billion) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Generic Drugs Market for Cardiovascular, By Country, 2020 & 2028
FIG NO. 22. Global Generic Drugs Market for Dermatology, Revenue (USD Billion) 2016 – 2028 
FIG NO. 23. Comparative Revenue Analysis of Generic Drugs Market for Dermatology, By Country, 2020 & 2028
FIG NO. 24. Global Generic Drugs Market for Oncology, Revenue (USD Billion) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Generic Drugs Market for Oncology By Country, 2020 & 2028
FIG NO. 26. Global Generic Drugs Market for Oncology, Revenue (USD Billion) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Generic Drugs Market for Oncology, By Country, 2020 & 2028
FIG NO. 28. Global Generic Drugs Market Revenue Share, By Region, 2020 & 2028
FIG NO. 29. North America Generic Drugs Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 30. Porter’s Five Forces Analysis for Global Generic Drugs Market
FIG NO. 31. PEST Analysis for Global Generic Drugs Market
FIG NO. 32. Pricing Analysis for Global Generic Drugs Market
FIG NO. 33. Value Chain Analysis for Global Generic Drugs Market
FIG NO. 34. Company Share Analysis, 2019
FIG NO. 35. Radar Determinant Chart, 2019
FIG NO. 36. Company Strategic Developments – Heat Map Analysis
FIG NO. 37. Teva Pharmaceutical Industries Ltd Business Segment Revenue Share, 2020 (%)
FIG NO. 38. Teva Pharmaceutical Industries Ltd Geographical Segment Revenue Share, 2020 (%)
FIG NO. 39. Market Channels 
FIG NO. 40. Marketing Channel Development Trend
FIG NO. 41. Growth in World Gross Product, 2008-2018
FIG NO. 42. Research Methodology – Detailed View
FIG NO. 43. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Generic Drugs Market: Snapshot
TABLE NO. 2. Quarterly Generic Drugs Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Generic Drugs Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Generic Drugs Market for Pure generic drugs, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Generic Drugs Market for Branded generic drugs, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Generic Drugs Market for Oncology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13: Global Generic Drugs Market for Central nervous system (CNS), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14: Global Generic Drugs Market for Cardiovascular, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Generic Drugs Market for Dermatology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. Global Generic Drugs Market for Oncology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. Global Generic Drugs Market for Respiratory, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 18. Global Generic Drugs Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 19. Global Generic Drugs Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 20: North America Generic Drugs Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 21. North America Generic Drugs Market Revenue, By Brand, 2016 – 2028 (USD Billion)
TABLE NO. 22: North America Generic Drugs Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 23. U.S. Generic Drugs Market Revenue, By Brand, 2016 – 2028 (USD Billion)
TABLE NO. 24. U.S. Generic Drugs Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 25. Canada Generic Drugs Market Revenue, By Brand, 2016 – 2028 (USD Billion)
TABLE NO. 26. Canada Generic Drugs Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 27. Mexico Generic Drugs Market Revenue, By Brand, 2016 – 2028 (USD Billion)
TABLE NO. 28: Mexico Generic Drugs Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 29 Drivers for the Generic Drugs Market: Impact Analysis
TABLE NO. 30. Restraints for the Generic Drugs Market: Impact Analysis
TABLE NO. 31. Major Buyers of Generic Drugs   
TABLE NO.32: Distributors/Traders List of Generic Drugs
TABLE NO. 33. Global Generic Drugs Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 34: Global Generic Drugs Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   

Methodology

FrequentlyAsked Questions

Zion Market Research has published a report on the global Generic Drugs Market, estimating its value at USD 359.27 Billion in 2023, with projections indicating that it will reach USD 593.71 Billion by 2032.

The market is expected to expand at a compound annual growth rate (CAGR) of 5.74% over the forecast period 2024-2032.

Some of the key factors driving the global Generic Drugs Market growth are new government initiatives to produce generic drugs and mainly to promote the use of generic drugs against chronic diseases.

North America is dominating the generic drug market due to high demand and increasing the prevalence of chronic diseases. Asia-Pacific is expected to show good growth in the forecast period.

Some of the major players of global Generic Drugs market Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Abbott Healthcare Pvt Ltd, Actavis Pharmaceuticals and Sun Pharmaceuticals.

Choose License Type

  • zion payment modes

List of Contents

Market InsightsOverviewGrowth FactorsSegment AnalysisReport ScopeRegional PreviewKey Market Players Competitive LandscapeThe global market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed